C. G. Mayhall

2.6k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

C. G. Mayhall is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Clinical Biochemistry. According to data from OpenAlex, C. G. Mayhall has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Clinical Biochemistry. Recurrent topics in C. G. Mayhall's work include Antimicrobial Resistance in Staphylococcus (9 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (3 papers). C. G. Mayhall is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (3 papers). C. G. Mayhall collaborates with scholars based in United States, Netherlands and Canada. C. G. Mayhall's co-authors include Pamela S. Falk, Yeşim Çetinkaya, Gordon L. Archer, Harry P. Dalton, V. Archer Lamb, William A. Rutala, Patricia A. Kelly, Kenneth J. Tarnowski, Andreas Voß and J. Joseph Marr and has published in prestigious journals such as PEDIATRICS, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

C. G. Mayhall

26 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vancomycin-Resistant Enterococci

2000 757 citations Yeşim Çetinkaya, Pamela S. Falk et al. Clinical Microbiology Reviews profile →

Peers

Countries citing papers authored by C. G. Mayhall

Since Specialization

Citations

This map shows the geographic impact of C. G. Mayhall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. G. Mayhall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. G. Mayhall more than expected).

Fields of papers citing papers by C. G. Mayhall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. G. Mayhall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. G. Mayhall. The network helps show where C. G. Mayhall may publish in the future.

Co-authorship network of co-authors of C. G. Mayhall

This figure shows the co-authorship network connecting the top 25 collaborators of C. G. Mayhall. A scholar is included among the top collaborators of C. G. Mayhall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. G. Mayhall. C. G. Mayhall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Changing Pattern of Infection After Major Vascular Reconstructions 2005 ·Vascular and Endovascular Surgery ·(unknown), (unknown), C. G. Mayhall, Pamela S. Falk, (unknown), Glenn C. Hunter, Lois A. Killewich	47
2	Ventilator-Associated Pneumonia or Not? Contemporary Diagnosis 2001 ·Emerging infectious diseases ·C. G. Mayhall	54
3	Vancomycin-Resistant Enterococci breakdown → 2000 ·Clinical Microbiology Reviews ·Yeşim Çetinkaya, Pamela S. Falk, C. G. Mayhall	757
4	The Society for Health Care Epidemiology of America 1998 ·Clinical Microbiology and Infection ·Andreas Voß, C. G. Mayhall	46
5	Nosocomial Sinusitis in Patients in the Medical Intensive Care Unit: A Prospective Epidemiological Study 1998 ·Clinical Infectious Diseases ·Donna L. George, Pamela S. Falk, G. Umberto Meduri, Kenneth V. Leeper, Richard G. Wunderink, Elaine L. Steere, (unknown), Neal S. Beckford, C. G. Mayhall	84
6	Intraamniotic infection in a teaching hospital [3] (multiple letters) 1997 ·American Journal of Obstetrics and Gynecology ·Leslie Iffy, Vijaya Ganesh, David E. Soper, C. G. Mayhall	1
7	Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome 1993 ·Antimicrobial Agents and Chemotherapy ·Thomas J. Walsh, Harold C. Standiford, Annette C. Reboli, Joseph F. John, Maury E. Mulligan, Bruce S. Ribner, John Z. Montgomerie, Matthew Bidwell Goetz, C. G. Mayhall, David Rimland	114
8	OSHA Bloodborne Hazard Standard 1992 ·Infection Control and Hospital Epidemiology ·Robert A. Weinstein, (unknown), Elías Abrutyn, (unknown), Donald E. Craven, Boston, John M. Boyce, (unknown), Loreen A. Herwaldt, (unknown), Peter Groß, C. G. Mayhall, (unknown), (unknown), Ludwig A. Lettau, (unknown), William Martone, (unknown), (unknown), (unknown), (unknown)	3
9	環境整備と医療廃棄物 (特集 EBMに基づいた環境整備) 1992 ·Infection Control and Hospital Epidemiology ·William A. Rutala, C. G. Mayhall	47
10	Medical Waste 1992 ·Infection Control and Hospital Epidemiology ·W A Rutala, C. G. Mayhall	26
11	Preventing central venous catheter-related complications. A roundtable discussion 1990 ·Thomas R. Beam, Edward L. Goodman, Barry M. Farr, Dennis G. Maki, C. G. Mayhall	8
12	Readability of Pediatric Biomedical Research Informed Consent Forms 1990 ·PEDIATRICS ·Kenneth J. Tarnowski, (unknown), C. G. Mayhall, Patricia A. Kelly	100
13	Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients 1988 ·Journal of Clinical Microbiology ·Lisa G. Kaplowitz, (unknown), Douglas M. Landwehr, Harry P. Dalton, C. G. Mayhall	62
14	Outbreak Due to Methicillin- and Refampin-Resistant Staphylococcus Aureus: epidemiology and eradication of the resistant strain from the hospital 1987 ·RePub (Erasmus University Rotterdam) ·(unknown), C. G. Mayhall, V. Archer Lamb, (unknown), (unknown), Harry P. Dalton	1
15	Streptococcus faecium outbreak in a neonatal intensive care unit 1984 ·Journal of Clinical Microbiology ·P E Coudron, C. G. Mayhall, Richard R. Facklam, (unknown), V. Archer Lamb, (unknown), Harry P. Dalton	70
16	Outbreak of Salmonella typhimurium gastroenteritis due to an imported strain resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole in a nursery 1984 ·Journal of Clinical Microbiology ·V. Archer Lamb, C. G. Mayhall, (unknown), Sheldon M. Markowitz, J. J. Farmer, Harry P. Dalton	22
17	Effect of storage and changes in bacterial growth phase and antibiotic concentrations on antimicrobial tolerance in Staphylococcus aureus 1980 ·Antimicrobial Agents and Chemotherapy ·C. G. Mayhall, (unknown)	44
18	Enterobacter cloacae Septicemia in a Bum Center: Epidemiology and Control of an Outbreak 1979 ·The Journal of Infectious Diseases ·C. G. Mayhall, V. Archer Lamb, (unknown), B. W. Haynes	72
19	In Vitro Activity of Five Oral Cephalosporins against Anaerobic Pathogenic Bacteria 1977 ·The Journal of Infectious Diseases ·Smith Shadomy, C. G. Mayhall, (unknown)	5
20	Variation in the Susceptibility of Strains of Staphylococcus aureus to Oxacillin, Cephalothin, and Gentamicin 1976 ·Antimicrobial Agents and Chemotherapy ·C. G. Mayhall, Gerald Medoff, J. Joseph Marr	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact